Abstract
Introduction
Patients with lymph node-positive urothelial carcinoma of the bladder generally have a poor prognosis. Nevertheless, long-term survival in up to 30 % of patients is reported. In the absence of established prognostic molecular markers, an assessment of the prognosis with clinical parameters is mandatory.
Patients and methods
All patients from one high-volume center with a curatively intended cystectomy for lymph node-positive urothelial carcinoma were evaluated. Patients’ overall and cancer-specific survival were correlated with clinicopathological parameters. Pathological lymph node staging was performed with both the 2002 and 2010 TNM classification of the AJCC.
Results
Lack of a perioperative chemotherapy (p < 0.001), higher numbers of positive nodes (p = 0.002), a higher lymph node density (p = 0.003), a higher pathological T stage (p = 0.006) and urinary diversion with an ileal conduit compared to an ileal neobladder (p = 0.023) were prognostic of a shorter overall survival while the number of removed lymph nodes showed no significant association with survival. Both with the 2002 and 2010 TNM classifications patients staged pN1 had a longer overall survival and time to cancer-specific death in comparison to patients with more extensive lymph node disease. According to the 2002 classification, there was a significant survival difference between patients with lymph node metastases in regional and distant lymph nodes.
Discussion
Patients with a low lymph node density and an early pT stage present with the best prognosis among LN positive patients. The value of perioperative chemotherapy is emphasized. Which lymph node metastases are to be considered regional or distant remains a matter of debate.
Similar content being viewed by others
References
Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675
Karl A, Carroll PR, Gschwend JE, Knuchel R, Montorsi F, Stief CG, Studer UE (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55(4):826–835. doi:10.1016/j.eururo.2009.01.004
Lehmann J, Retz M, Wiemers C, Beck J, Thuroff J, Weining C, Albers P, Frohneberg D, Becker T, Funke PJ, Walz P, Langbein S, Reiher F, Schiller M, Miller K, Roth S, Kalble T, Sternberg D, Wellek S, Stockle M (2005) Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). J Clin Oncol 23(22):4963–4974. doi:10.1200/jco.2005.11.094
May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wulfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Hofner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Muller SC, Stief CG, Bastian PJ (2011) Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol 59(5):712–718. doi:10.1016/j.eururo.2011.01.030
Sobin L, Wittekind C (2002) International Union against Cancer. TNM classification of malignant tumors. Wiley-Liss, New York
Edge SB (2010) American Joint Committee on Cancer. AJCC cancer staging manual. Springer, New York
Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, Dinney CP, Tilki D, Kamat AM, Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC (2011) Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol. doi:10.1016/j.urolonc.2011.02.011
Jeong IG, Park J, Song K, Ro JY, Song C, Hong JH, Ahn H, Kim CS (2011) Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed. Urol Oncol 29(2):199–204. doi:10.1016/j.urolonc.2009.04.006
Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF (2009) Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol 182(5):2182–2187. doi:10.1016/j.juro.2009.07.017
Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF (2012) Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Eur Urol. doi:10.1016/j.eururo.2012.07.026
Seiler R, von Gunten M, Thalmann GN, Fleischmann A (2011) Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer. Histopathology 58(4):571–578. doi:10.1111/j.1365-2559.2011.03778.x
Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF (2013) Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int 111(1):74–84. doi:10.1111/j.1464-410X.2012.11356.x
Stein JP, Cai J, Groshen S, Skinner DG (2003) Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170(1):35–41. doi:10.1097/01.ju.0000072422.69286.0e
Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346
Tarin TV, Power NE, Ehdaie B, Sfakianos JP, Silberstein JL, Savage CJ, Sjoberg D, Dalbagni G, Bochner BH (2012) Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol 61(5):1025–1030. doi:10.1016/j.eururo.2012.01.049
Jensen JB, Ulhoi BP, Jensen KM (2012) Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery. BJU Int 109(3):388–393. doi:10.1111/j.1464-410X.2011.10369.x
Bruins HM, Dorin RP, Rubino B, Miranda G, Cai J, Daneshmand S, Skinner EC (2012) Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy. Eur Urol 62(4):671–676. doi:10.1016/j.eururo.2012.04.050
Jeong IG, You D, Kim JW, Song C, Hong JH, Ahn H, Kim CS (2011) Outcomes of single lymph node positive urothelial carcinoma after radical cystectomy. J Urol 185(6):2085–2090. doi:10.1016/j.juro.2011.02.056
Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, Thuroff JW (2009) Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int 104(3):331–335. doi:10.1111/j.1464-410X.2009.08403.x
Park J, Kim S, Jeong IG, Song C, Hong JH, Kim CS, Ahn H (2011) Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy? World J Urol 29(4):443–449. doi:10.1007/s00345-011-0644-9
Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM (2006) Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 176(1):53–57. doi:10.1016/s0022-5347(06)00510-6
Morgan TM, Barocas DA, Penson DF, Chang SS, Ni S, Clark PE, Smith JA Jr, Cookson MS (2012) Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. Urology 80(3):632–640. doi:10.1016/j.urology.2012.03.070
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
This analysis has been approved by the local ethics committee (Application Number 5891/13) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horn, T., Schmid, S.C., Seitz, A.K. et al. Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent. World J Urol 33, 813–819 (2015). https://doi.org/10.1007/s00345-014-1355-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-014-1355-9